Longitudinal changes in tumour size since baseline for patients by changes in ctDNA status (clearance, decrease or increase) since baseline.
Tumour size change over time
Longitudinal changes in tumour size since baseline for patients by changes in ctDNA status (clearance, decrease or increase) since baseline.
ctDNA
A data frame with 270 rows and 5 variables:
Patient ID
Study Cohort: A = Squamous cell carcinoma of soft pallate, B = Triple negative breast cancer, C = Ovarian, high grade serous, D = Melanoma, E = Other Solid Tumor
Change in ctDNA since baseline
Number of weeks on treatment
Percentage change in tumour measurement